Practice
Open Access
Maculopathy caused by pentosan polysulfate
Daniel Rosenberg, David Sarraf and Varun Chaudhary
CMAJ May 03, 2021 193 (18) E645; DOI: https://doi.org/10.1503/cmaj.201900
Daniel Rosenberg
Michael G. DeGroote School of Medicine (Rosenberg), McMaster University, Hamilton, Ont.; Stein Eye Institute (Sarraf), David Geffen School of Medicine, University of California Los Angeles; Greater Los Angeles Veterans Administration Healthcare Center (Sarraf), Los Angeles, Calif.; Division of Ophthalmology (Chaudhary), Department of Surgery, and Department of Health Research Methods, Evidence and Impact (HEI) (Chaudhary), McMaster University; St. Joseph’s Healthcare Hamilton and McMaster University (Chaudhary), Hamilton, Ont.
BScDavid Sarraf
Michael G. DeGroote School of Medicine (Rosenberg), McMaster University, Hamilton, Ont.; Stein Eye Institute (Sarraf), David Geffen School of Medicine, University of California Los Angeles; Greater Los Angeles Veterans Administration Healthcare Center (Sarraf), Los Angeles, Calif.; Division of Ophthalmology (Chaudhary), Department of Surgery, and Department of Health Research Methods, Evidence and Impact (HEI) (Chaudhary), McMaster University; St. Joseph’s Healthcare Hamilton and McMaster University (Chaudhary), Hamilton, Ont.
MDVarun Chaudhary
Michael G. DeGroote School of Medicine (Rosenberg), McMaster University, Hamilton, Ont.; Stein Eye Institute (Sarraf), David Geffen School of Medicine, University of California Los Angeles; Greater Los Angeles Veterans Administration Healthcare Center (Sarraf), Los Angeles, Calif.; Division of Ophthalmology (Chaudhary), Department of Surgery, and Department of Health Research Methods, Evidence and Impact (HEI) (Chaudhary), McMaster University; St. Joseph’s Healthcare Hamilton and McMaster University (Chaudhary), Hamilton, Ont.
MDIn this issue
Article tools
Maculopathy caused by pentosan polysulfate
Daniel Rosenberg, David Sarraf, Varun Chaudhary
CMAJ May 2021, 193 (18) E645; DOI: 10.1503/cmaj.201900
Jump to section
- Article
- Pentosan polysulfate (PPS) is a mainstay for treatment of bladder pain associated with interstitial cystitis
- Maculopathy is associated with longer duration of PPS use
- Maculopathy caused by PPS may masquerade as age-related macular degeneration
- Macular disease may progress even after cessation of PPS
- Patients exposed to PPS who report disturbed vision should undergo ophthalmic screening
- Footnotes
- References
- Responses
- Metrics
Related Articles
Cited By...
- No citing articles found.